Clinical trials
Central Venous Catheter clinical trials
Below are recruiting central venous catheter clinical trials, each written for real people, not researchers. We’re tracking 36 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06885073Recruiting
A new way to check vein pressure in children without needles
This trial tests a new way to measure pressure inside a major vein in the chest without needing to stick any needles. It might be an option for children and young adults up to age 21 who already have a central line or are getting a heart catheter.
Washington D.C., District of ColumbiaAges Up to 21 years - NCT05050799Recruiting
Testing a new device to place central lines in harder cases
This study tracks how well a new device (the Surfacer System) works when standard methods can’t place a central venous line (a larger tube into a major vein). It may help people who need a long-term access line but have blocked veins where usual procedures don’t work.
Tucson, ArizonaAges 18 years+ - NCT07219758Recruiting
Recana device study for leg vein blockages
This trial tests a new device called the Recana Thrombectomy Catheter to clear blockages in the large veins of the legs or pelvis. It might help people with chronic leg swelling, pain, or open sores caused by poor blood flow out of the leg.
LondonAges 18 years+ - NCT07450729Recruiting
IV catheter use study in children in the ER
This study looks at how IV catheters work in children who come to the emergency room and need an IV for at least 24 hours. It will help doctors understand the best ways to use and care for IVs in kids.
FlorenceAges birth–18 years - NCT07567456Recruiting
Flushing technique to prevent catheter blockage in dialysis
This study tests a new flushing method to help prevent blood clots from blocking dialysis catheters. If it works, it could reduce painful procedures and keep your access working longer.
KowloonAges 18 years+ - NCT03418038RecruitingPhase 2
Vitamin C with chemotherapy for certain relapsed blood cancers
This Phase 2 trial tests whether intravenous vitamin C (ascorbic acid) added to chemotherapy can improve outcomes for people with certain relapsed or treatment-resistant lymphomas or chronic myelomonocytic leukemia (CMML). It may help by boosting chemotherapy’s effectiveness and/or changing how the cancer responds.
Mankato, MinnesotaAges 18 years+ - NCT06180902Recruiting
Testing fluid response methods in patients with reduced consciousness
This trial compares different ways to check if a patient in the ICU with lowered consciousness needs more IV fluids. It aims to find the most accurate method, which could help doctors give the right amount of fluid.
MoscowAges 18 years+ - NCT07095660Recruiting
Catheter device for leg vein blockages
This trial tests a new catheter device to remove blockages in the large veins of your legs. It may help if you have chronic leg swelling or pain from vein problems.
GalwayAges 18 years+ - NCT04871568Recruiting
Compare two sites for dialysis catheter placement
This trial tests whether placing a dialysis catheter in one location (subclavian/near the collarbone) is as good as placing it in another (jugular/neck) for patients who need a temporary dialysis catheter. It aims to reduce problems like vein narrowing caused by catheter placement.
LundAges 18 years+ - NCT05537389Recruiting
Test safety of IV central lines in newborns
This study checks how safe it is to place and use a central venous catheter (a special IV line) in newborns in the NICU. It may help doctors use these lines more safely when they’re needed.
Torino, ItaliaAges 1 hour–3 months - NCT04924322RecruitingPhase 2/Phase 3
Early blood clot prevention after certain central line insertions
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
Birmingham, AlabamaAges Up to 17 years - NCT05935228Recruiting
Tool to improve management of IV line placement
This study tests an algorithm (a step-by-step decision tool) to help healthcare teams manage peripheral IV lines. It may help reduce problems like failed IV access and improve how IV lines are handled over time.
Vandœuvre-lès-NancyAges 18 years+
Hear when a new Central Venous Catheter trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for central venous catheter?
- Yes. Clin2 currently lists 36 recruiting central venous catheter studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a central venous catheter trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a central venous catheter trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.